Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Index funds win long term largely because of lower costs and broad diversification. This brief introduces the cost advantage and payoff.
27,987 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Thinking about leaving the workforce earlier than planned? These five practical signals can help you spot when you ma...
Sen. Ron Wyden is pushing Senate leadership to retain protections for blockchain developers in a sweeping crypto bill...
As AI romance apps grow, couples and singles are juggling digital affection with real budgets. Learn how crypto payme...
An autonomous AI wallet on Solana accidentally moved a six-figure sum of tokens to a random address, sparking a wild ...
A widening Iran conflict threatens energy supplies and household budgets, prompting new warnings that the crisis coul...
When a Dentsply Sirona director buys a large block of shares, investors take notice. This article breaks down what th...
In a tightening insurance landscape, resilience upgrades are becoming the default. This report examines how builders ...
Super Micro Computer reports revenue that more than doubles year over year, yet the shares sit flat as questions abou...
Investors are shifting focus from Intel to overlooked chip stocks delivering real cash flow and AI-driven demand, led...
The U.S. government has agreed to drop current tax claims against former President Trump, his family, and the Trump O...
In Knoxville, some seniors can retire on Social Security alone, but success hinges on housing status, equity, and dis...